Cipla’s arm to pick up 13.10% stake in Jiangsu

01 Sep 2022 Evaluate

Cipla’s wholly owned subsidiary in UK -- Cipla (EU) is all set to acquire an additional 13.10% stake in Cipla (Jiangsu) Pharmaceutical, a subsidiary of Cipla EU in China. Post-acquisition, Cipla EU's stake in the subsidiary, will increase to 93.10%. The cost of acquisition is $16.40 million. The object of the acquisition is to provide quality drugs and strengthen presence in China.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1243.50 -12.35 (-0.98%)
23-Mar-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.40
Dr. Reddys Lab 1276.65
Cipla 1243.50
Zydus Lifesciences 877.90
Lupin 2287.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×